161 related articles for article (PubMed ID: 38491801)
1. Construction of a prognostic model for breast cancer based on moonlighting genes.
Zhang M; Zhang D; Wang Q; Lin G
Hum Mol Genet; 2024 Jun; 33(12):1023-1035. PubMed ID: 38491801
[TBL] [Abstract][Full Text] [Related]
2. Detecting prognostic biomarkers of breast cancer by regularized Cox proportional hazards models.
Li L; Liu ZP
J Transl Med; 2021 Dec; 19(1):514. PubMed ID: 34930307
[TBL] [Abstract][Full Text] [Related]
3. HER2 low expression breast cancer subtyping and their correlation with prognosis and immune landscape based on the histone modification related genes.
Li J; Yao J; Qi L
Sci Rep; 2023 Dec; 13(1):21753. PubMed ID: 38066224
[TBL] [Abstract][Full Text] [Related]
4. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
5. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer.
Zhao X; Lin J
Comput Math Methods Med; 2022; 2022():6532591. PubMed ID: 36267313
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer.
Ren X; Cui H; Dai L; Chang L; Liu D; Yan W; Zhao X; Kang H; Ma X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):119. PubMed ID: 38466449
[TBL] [Abstract][Full Text] [Related]
7. Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma.
Peng T; Sun F; Yang JC; Cai MH; Huai MX; Pan JX; Zhang FY; Xu LM
World J Gastroenterol; 2024 May; 30(19):2575-2602. PubMed ID: 38817665
[TBL] [Abstract][Full Text] [Related]
8. Analysing a Novel RNA-Binding-Protein-Related Prognostic Signature Highly Expressed in Breast Cancer.
Lan Y; Su J; Xue Y; Zeng L; Cheng X; Zeng L
J Healthc Eng; 2021; 2021():9174055. PubMed ID: 34707800
[TBL] [Abstract][Full Text] [Related]
9. A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer.
Wang J; Yang Z; Zhang C; Ouyang J; Zhang G; Wu C
Gene; 2020 Nov; 761():145049. PubMed ID: 32791092
[TBL] [Abstract][Full Text] [Related]
10. Identification and Prognostic Value Exploration of Cyclophosphamide (Cytoxan)-Centered Chemotherapy Response-Associated Genes in Breast Cancer.
Du J; Dong Y; Li Y
DNA Cell Biol; 2021 Nov; 40(11):1356-1368. PubMed ID: 34704810
[TBL] [Abstract][Full Text] [Related]
11. Identification of a pyroptosis-related prognostic signature in breast cancer.
Chen H; Luo H; Wang J; Li J; Jiang Y
BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
[TBL] [Abstract][Full Text] [Related]
12. Identification of Breast Cancer Immune-related Prognostic Characteristics in Tumor Microenvironment.
Tang Z; Li L; Huang X; Zhao Y; Liu Q; Zhang C
Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38213151
[TBL] [Abstract][Full Text] [Related]
13. Characterization of alternative splicing events and prognostic signatures in breast cancer.
Han P; Zhu J; Feng G; Wang Z; Ding Y
BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysis.
Yang Y; Li Z; Zhong Q; Zhao L; Wang Y; Chi H
Gland Surg; 2022 May; 11(5):892-912. PubMed ID: 35694087
[TBL] [Abstract][Full Text] [Related]
15. A six-gene-based signature for breast cancer radiotherapy sensitivity estimation.
Chen X; Zheng J; Zhuo ML; Zhang A; You Z
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33179733
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed genes-related prognostic risk model for survival prediction in breast carcinoma patients.
Li J; Huang G; Ren C; Wang N; Sui S; Zhao Z; Li M
Aging (Albany NY); 2021 Jun; 13(12):16577-16599. PubMed ID: 34175839
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognostic genes for breast cancer related to systemic lupus erythematosus by integrated analysis and machine learning.
Liang X; Peng Z; Lin Z; Lin X; Lin W; Deng Y; Yang S; Wei S
Immunobiology; 2023 Sep; 228(5):152730. PubMed ID: 37582308
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer.
Liu X; Wang W; Chen B; Wang S
Aging (Albany NY); 2024 Apr; 16(8):7188-7216. PubMed ID: 38643462
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation.
Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G
Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414
[TBL] [Abstract][Full Text] [Related]
20. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
Mo W; Ding Y; Zhao S; Zou D; Ding X
PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
